Tirzepatide

Service Description

With its potent combination of GLP-1 and GIP agonism, Tirzepatide offers unparalleled effectiveness in curbing appetite and promoting weight loss. Clinical trials have shown impressive results, with participants experiencing significant reductions in body weight and improved metabolic markers. In comparison to its competitor Semaglutide, Tirzepatide has marked improvement in reported side effects with quicker results. Dosage increases every 4 weeks. Injections are given weekly in the abdomen, arm or upper thigh. Dosages: 2.5mg, 5mg, 7.5mg and 10mg. You want a kick start? Add the Med.ish Stack WeightLoss Program